Zebrafish brain proteomics reveals central proteins involved in neurodegeneration

Journal of Neuroscience Research

Volumn 92, Issue 1, 2014, Pages 104-115

  Gebriel, Mohammed ^a   Prabhudesai, Shubhangi ^b   Uleberg, Kai Erik ^c,d,e   Larssen, Eivind ^c   Piston, Dominik ^a,d   Bjørnstad, Anne Hjelle ^c   Møller, Simon Geir ^a,b,d  

^a UNIVERSITY OF STAVANGER   (Norway)

^b ST JOHN'S UNIVERSITY   (United States)

^c INTERNATIONAL RESEARCH INSTITUTE OF STAVANGER   (Norway)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e UNIVERSITY OF BERGEN   (Norway)

Author keywords

Brain; Neurodegeneration; Proteomics; Zebrafish

Indexed keywords

BRAIN PROTEIN; PROTEOME;

ANIMAL TISSUE; ARTICLE; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; SUMOYLATION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UBIQUITINATION; ZEBRA FISH;

BRAIN; NEURODEGENERATION; PROTEOMICS; ZEBRAFISH;

ANIMALS; BRAIN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLYCOSYLATION; NERVE DEGENERATION; PHOSPHORYLATION; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84888073546     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23297     Document Type: Article

References (59)

1. Arimura N, Inagaki N, Chihara K, Ménager C, Nakamura N, Amano M, Iwamatsu A, Goshima Y, Kaibuchi K. 2000. Phosphorylation of collapsin response mediator protein-2 by rho-kinase. Evidence for two separate signaling pathways for growth cone collapse. J Biol Chem 275:23973-23980.
2. Basso M, Giraudo S, Corpillo D, Bergamasco B, Lopiano L, Fasano M. 2004. Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics 4:3943-3952.
3. Bayes A, Grant SG. 2009. Neuroproteomics: understanding the molecular organization and complexity of the brain. Nat Rev Neurosci 10:635-646.
4. Becker M, Schindler J, Nothwang HG. 2006. Neuroproteomics-the tasks lying ahead. Electrophoresis 27:2819-2829.
5. Berg D, Holzmann C, Riess O. 2003. 14-3-3 Proteins in the nervous system. Nat Rev Neurosci 4:752-762.
6. Bhatia VN, Perlman DH, Costello CE, McComb ME. 2009. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem 81:9819-9823.
7. Blesa J, Phani S, Jackson-Lewis V, Przedborski S. 2012. Classic and new animal models of Parkinson's disease. J Biomed Biotechnol 2012:845618. doi: 10.1155/2012/845618.
8. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, Orecchia P, Zardi L, Righetti PG. 2004. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25:1327-1333.
9. Cartier AE, Ubhi K, Spencer B, Vazquez-Roque RA, Kosberg KA, Fourgeaud L, Kanayson P, Patrick C, Rockenstein E, Patrick GN, Masliah E. 2012. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy. PLoS One 7:e34713.
10. Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA. 2002. Proteomic identification of BB, oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic Biol Med 33:562-571.
11. Chen HM, Lin CY, Wang V. 2011. Amyloid P component as a plasma marker for Parkinson's disease identified by a proteomic approach. Clin Biochem 44:377-385.
12. Cheroni C, Peviani M, Cascio P, Debiasi S, Monti C, Bendotti C. 2005. Accumulation of human SOD1 and ubiquitinated deposits in the spinal cord of SOD1G93A mice during motor neuron disease progression correlates with a decrease of proteasome. Neurobiol Dis 18:509-522.
13. de Vries RL, Przedborski S. 2012. Mitophagy and Parkinson's disease: be eaten to stay healthy. Mol Cell Neurosci (in press).
14. Faes L, Callewaert G. 2011. Mitochondrial dysfunction in familial amyotrophic lateral sclerosis. J Bioenerg Biomembr 43:587-592.
15. Federico A, Cardaioli E, Da Pozzo P, Formichi P, Gallus GN, Radi E. 2012. Mitochondria, oxidative stress and neurodegeneration. J Neurol Sci 322:254-262.
16. Foote M, Zhou Y. 2012. 14-3-3 Proteins in neurological disorders. Int J Biochem Mol Biol. 3:152-164.
17. Fukai T, Ushio-Fukai M. 2011. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583-1606.
18. Fukata Y, Oshiro N, Kinoshita N, Kawano Y, Matsuoka Y, Bennett V, Matsuura Y, Kaibuchi K. 1999. Phosphorylation of adducin by rho-kinase plays a crucial role in cell motility. J Cell Biol 145:347-361.
19. Goswami T, Li X, Smith AM, Luderowski EM, Vincent JJ, Rush J, Ballif BA. 2012. Comparative phosphoproteomic analysis of neonatal and adult murine brain. Proteomics 12:2185-2189.
20. Grant P, Pant HC. 2000. Neurofilament protein synthesis and phosphorylation. J Neurocytol 29:843-872.
21. Grimm S, Hoehn A, Davies KJ, Grune T. 2011. Protein oxidative modifications in the ageing brain: consequence for the onset of neurodegenerative disease. Free Radic Res 45:73-88.
22. Hernández MP, Sullivan WP, Toft DO. 2002. The assembly and intermolecular properties of the hsp70-Hop-hsp90 molecular chaperone complex. J Biol Chem 277:38294-38304.
23. Hino M, Kijima-Suda I, Nagai Y, Hosoya H. 2003. Glycosylation of the alpha and beta tubulin by sialyloligosaccharides. Zool Sci 20:709-715.
24. Huang daW, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using David bioinformatics resources. Nat Protoc 4:44-57.
25. Hwang H, Zhang J, Chung KA, Leverenz JB, Zabetian CP, Peskind ER, Jankovic J, Su Z, Hancock AM, Pan C, Montine TJ, Pan S, Nutt J, Albin R, Gearing M, Beyer RP, Shi M, Zhang J. 2010. Glycoproteomics in neurodegenerative diseases. Mass Spectrom Rev 29:79-125.
26. Kamphuis W, Mamber C, Moeton M, Kooijman L, Sluijs JA, Jansen AH, Verveer M, de Groot LR, Smith VD, Rangarajan S, Rodríguez JJ, Orre M, Hol EM. 2012. GFAP isoforms in adult mouse brain with a focus on neurogenic astrocytes and reactive astrogliosis in mouse models of Alzheimer disease. PLoS One 7:e42823.
27. Kawabe H, Brose N. 2011. The role of ubiquitylation in nerve cell development. Nat Rev Neurosci 12:251-268.
28. Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, Glucksman MJ. 2004. Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem Res 29:1317-1331.
29. Korolainen MA, Auriola S, Nyman TA, Alafuzoff I, Pirttilä T. 2005. Proteomic analysis of glial fibrillary acidic protein in Alzheimer's disease and aging brain. Neurobiol Dis 20:858-870.
30. Lehman NL. 2009. The ubiquitin proteasome system in neuropathology. Acta Neuropathol 118:329-347.
31. Lehnert S, Jesse S, Rist W, Steinacker P, Soininen H, Herukka SK, Tumani H, Lenter M, Oeckl P, Ferger B, Hengerer B, Otto M. 2012. iTRAQ and multiple reaction monitoring as proteomic tools for biomarker search in cerebrospinal fluid of patients with Parkinson's disease dementia. Exp Neurol 234:499-505.
32. Magrané J, Hervias I, Henning MS, Damiano M, Kawamata H, Manfredi G. 2009. Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities. Hum Mol Genet 18:4552-4564.
33. Martin LJ. 2007. Transgenic mice with human mutant genes causing Parkinson's disease and amyotrophic lateral sclerosis provide common insight into mechanisms of motor neuron selective vulnerability to degeneration. Rev Neurosci 18:115-136.
34. Matsuoka Y, Li X, Bennett V. 2000. Adducin: structure, function and regulation. Cell Mol Life Sci 57:884-895.
35. Menegon A, Board PG, Blackburn AC, Mellick GD, Le Couteur DG. 1998. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Lancet 352:1344-1346.
36. Mhatre M, Floyd RA, Hensley K. 2004. Oxidative stress and neuroinflammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimers Dis 6:147-157.
37. Murakami K, Murata N, Noda Y, Tahara S, Kaneko T, Kinoshita N, Hatsuta H, Murayama S, Barnham KJ, Irie K, Shirasawa T, Shimizu T. 2011. SOD1 (copper/zinc superoxide dismutase) deficiency drives amyloid β protein oligomerization and memory loss in mouse model of Alzheimer disease. J Biol Chem 286:44557-44568.
38. Nagley P, Higgins GC, Atkin JD, Beart PM. 2010. Multifaceted deaths orchestrated by mitochondria in neurones. Biochim Biophys Acta 1802:167-185.
39. Nishioka K, Wider C, Vilariño-Güell C, Soto-Ortolaza AI, Lincoln SJ, Kachergus JM, Jasinska-Myga B, Ross OA, Rajput A, Robinson CA, Ferman TJ, Wszolek ZK, Dickson DW, Farrer MJ. 2010. Association of alpha-, beta-, and gamma-Synuclein with diffuse lewy body disease. Arch Neurol 67:970-975.
40. Radivojac P, Vacic V, Haynes C, Cocklin RR, Mohan A, Heyen JW, Goebl MG, Iakoucheva LM. 2010. Identification, analysis and prediction of protein ubiquitination sites. Proteins Structure Function Bioinformatics 78:365-380.
41. Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R. 2005. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem 95:1461-1471.
42. Reijn TS, Abdo WF, Schelhaas HJ, Verbeek MM. 2009. CSF neurofilament protein analysis in the differential diagnosis of ALS. J Neurol 256:615-619.
43. Robinson PA. 2010. Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy. Expert Rev Proteomics 7:565-578.
44. Rothstein JD. 2009. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3-S9.
45. Ryberg H, An J, Darko S, Lustgarten JL, Jaffa M, Gopalakrishnan V, Lacomis D, Cudkowicz M, Bowser R. 2010. Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle Nerve 42:104-111.
46. Shi M, Bradner J, Bammler TK, Eaton DL, Zhang J, Ye Z, Wilson AM, Montine TJ, Pan C, Zhang J. 2009. Identification of glutathione S-transferase pi as a protein involved in Parkinson disease progression. Am J Pathol 175:54-65.
47. Singh SK, Sundaram CS, Shanbhag S, Idris MM. 2010. Proteomic profile of zebrafish brain based on two-dimensional gel electrophoresis matrix-assisted laser desorption/ionization MS/MS analysis. Zebrafish 7:169-177.
48. Smeyne M, Boyd J, Raviie Shepherd K, Jiao Y, Pond BB, Hatler M, Wolf R, Henderson C, Smeyne RJ. 2007. GSTpi expression mediates dopaminergic neuron sensitivity in experimental parkinsonism. Proc Natl Acad Sci U S A 104:1977-1982.
49. Stachowiak JC, Schmid EM, Ryan CJ, Ann HS, Sasaki DY, Sherman MB, Geissler PL, Fletcher DA, Hayden CC. 2012. Membrane bending by protein-protein crowding. Nat Cell Biol 14:944-949.
50. Steinacker P, Aitken A, Otto M. 2011. 14-3-3 Proteins in neurodegeneration. Semin Cell Dev Biol 22:696-704.
51. Ström AL, Shi P, Zhang F, Gal J, Kilty R, Hayward LJ, Zhu H. 2008. Interaction of amyotrophic lateral sclerosis (ALS)-related mutant copper-zinc superoxide dismutase with the dynein-dynactin complex contributes to inclusion formation. J Biol Chem 283:22795-22805.
52. Takei YI, Oguchi K, Koshihara H, Hineno A, Nakamura A, Ohara S. 2013. α-Synuclein coaggregation in familial amyotrophic lateral sclerosis with SOD1 gene mutation. Hum Pathol S0046-8177(12)00422-4 (in press).
53. Tateno M, Kato S, Sakurai T, Nukina N, Takahashi R, Araki T. 2009. Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum Mol Genet 18:942-955.
54. Wang J, Xu G, Borchelt DR. 2002. High molecular weight complexes of mutant superoxide dismutase 1: age-dependent and tissue-specific accumulation. Neurobiol Dis 9:139-148.
55. Westerfield M. 2000. The zebrafish book. A guide for the laboratory use of zebrafish Danio rerio, 4th ed. Eugene, OR: University of Oregon Press.
56. Xu XM, Lin H, Maple J, Björkblom B, Alves G, Larsen JP, Møller SG. 2010. The arabidopsis DJ-1a protein confers stress protection through cytosolic SOD activation. J Cell Sci 123:1644-1651.
57. Yuan Z, Agarwal-Mawal A, Paudel HK. 2004. 14-3-3 Binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3beta in the brain. J Biol Chem 279:26105-26114.
58. Zabel M, Schrag M, Mueller C, Zhou W, Crofton A, Petersen F, Dickson A, Kirsch WM. 2012. Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. J Alzheimers Dis 30:311-321.
59. Zhou JY, Afjehi-Sadat L, Asress S, Duong DM, Cudkowicz M, Glass JD, Peng J. 2010. Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approach. J Proteome Res 9:5133-5141.